Back

The impact of soluble guanylate cyclase stimulator on cardiac and venous return characteristics: a framework analysis using generalized circulatory equilibrium

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Haemodynamics and heart failure Haemodynamics of Heart Failure ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Daiki Suzuki

National Cerebral and Cardiovascular Centre, Osaka (Japan)

7 More presentations in this session

Presentation thumbnail
Left atrial remodeling and functional maladaptations in obesity: an invasive pressure-volume analysis
Doctor L. Monzo (Vandoeuvre-Les-Nancy, FR)
Abstract
Presentation thumbnail
Prolonged oxygen pulse oscillation during cardiopulmonary exercise testing identifies subclinical pulmonary congestion in heart failure
Doctor H. Radillo (Guadalajara, MX)
Abstract
Presentation thumbnail
Gaussian mixture modelling of invasive haemodynamics identifies reproducible phenotypes and risk gradients in a broad spectrum of cardiovascular disease
Doctor J. Haurand (Duesseldorf, DE)
Abstract
Presentation thumbnail
Stage-specific pulmonary pressure response and RV–PA coupling during exercise in HFpEF
Doctor S. Lee (Seoul, KR)
Abstract
Presentation thumbnail
Discordance between reported functional limitation and objective exercise capacity assessed by cardiopulmonary exercise testing in heart failure
Doctor L. Lorenzo Alves (Porto, PT)
Abstract

Access the full session

Session thumbnail
Haemodynamics and heart failure

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Assessment of cardiac reverse remodeling in patients with LV systolic dysfunction receiving vericiguat in addition to optimal GDMT
13 December 2024
thumbnail
Congress Presentation
The effect of a higher blood pressure-target on volume and venous return in comatose out of hospital cardiac arrest patients
14 March 2025
thumbnail
Congress Presentation
Arginase 1 in erythrocytes is a critical modulator of cardioprotective signalling by nitric oxide and soluble guanylyl cyclase
26 August 2022
thumbnail
Congress Presentation
Physiologically-based pharmacokinetic (PBPK) exploration of extrinsic factors influencing vericiguat pharmacokinetics
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources